ServiceUpdated on 27 January 2025
Due Diligence Assessment
About
> Report identifying and assessing important regulatory issues of an asset
> Conducted in multiple conditions and stages of development (e.g., FIH, prior to certification), both for licensing and for acquisition
> Provide recommendations on potential regulatory implications and requirements and go/no-go decision from the regulatory perspective
Type
- Consulting
Organisation
Similar opportunities
Service
- Medtech
- Consulting
- Biotech and Lifescience
Tabatha Bourgois
Director, Regulatory and Clinical Development at Alira Health
Barcelona, Spain
Product
Elly - Regulatory Affairs Assistant
- Medtech
Michael Galliker
Founder and CEO at Regulatory Globe GmbH
Oberdorf NW, Switzerland
Product
Support Quality Management and Regulatory Affairs
Bernhard Nussbaumer
Shareholder & CBDO at ACMIT Gmbh
Wiener Neustadt, Austria